Sacroiliitis Market Research Report – Forecast to 2027

Sacroiliitis Market Research Report, by Diagnosis (Imaging Tests and Anesthetic Injections), Treatment (Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation), End-User (Hospitals, Diagnostic Centers) – Global Forecast Till 2027

ID: MRFR/Pharma/4829-HCR | | Region: Global | 100 Pages         

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Sacroiliitis Market, by Diagnosis,

6.1 Introduction

6.2 Imaging Tests

6.2.1 X-ray

6.2.2 MRI

6.2.3 CT scan

6.3 Anesthetic Injections

Chapter 7. Global Sacroiliitis Market, by Treatment

7.1 Introduction

7.2 Medications

7.2.1 Pain Relievers

7.2.1 Muscle Relaxants

7.2.3 TNF Inhibitors

7.3 Joint Injections

7.4 Radiofrequency Denervation

7.5 Electrical Stimulation

7.6 Joint Fusion

7.7 Facet Block

7.8 Chiropractic Manipulation

7.9 Physical Therapy

Chapter 9. Global Sacroiliitis Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

9.3 Pharmacies

9.4 Diagnostic Centers

Chapter 10. Global Sacroiliitis Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Medacta International

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 SI-BONE

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Globus Medical

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Zyga Technology

12.4.1 Company Overview

12.4.2 Product Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Nutech Medical

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 CoorsTek Medical LLC

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 ASPEN MEDICAL PRODUCTS

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Medtronic

12.8.1 Overview

12.8.2 Product Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.16 Others

Chapter 14 Appendix

LIST OF TABLES

Table 1 Sacroiliitis Market Industry Synopsis, 2020–2027

Table 2 Global Sacroiliitis Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Global Sacroiliitis Market, by Region, 2020–2027, (USD Million)

Table 4 Global Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 5 Global Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 6 Global Sacroiliitis Market, by End-User, 2020–2027, (USD Million

Table 7 North America: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 8 North America: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 9 North America: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 10 US: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 11 US: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 12 US: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 13 Canada: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 Canada: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 15 Canada: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 16 South America: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 17 South America: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 18 South America: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 19 Europe: Sacroiliitis Market, Diagnosis, 2020–2027, (USD Million)

Table 20 Europe: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 21 Europe: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 22 Western Europe: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 23 Western Europe: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 24 Western Europe: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 25 Eastern Europe: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Eastern Europe: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 27 Eastern Europe: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 28 Asia-Pacific: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 29 Asia-Pacific: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 30 Asia-Pacific: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

Table 31 Middle East & Africa: Sacroiliitis Market, by Diagnosis, 2020–2027, (USD Million)

Table 32 Middle East & Africa: Sacroiliitis Market, by Treatment, 2020–2027, (USD Million)

Table 33 Middle East & Africa: Sacroiliitis Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Sacroiliitis Market

Figure 3 Market Dynamics for Global Sacroiliitis Market

Figure 4 Global Sacroiliitis Market Share, by Diagnosis 2020

Figure 5 Global Sacroiliitis Market Share, by Treatment 2020

Figure 6 Global Sacroiliitis Market Share, by End-User, 2020

Figure 7 Global Sacroiliitis Market Share, by Region, 2020

Figure 8 North America Sacroiliitis Market Share, by Country, 2020

Figure 9 Europe Sacroiliitis Market Share, by Country, 2020

Figure 10 Asia-Pacific Sacroiliitis Market Share, by Country, 2020

Figure 11 Middle East & Africa Sacroiliitis Market Share, by Country, 2020

Figure 12 Global Sacroiliitis Market: Company Share Analysis, 2020 (%)

Figure 13 Medacta International: Key Financials

Figure 14 Medacta International: Segmental Revenue

Figure 15 Medacta International: Geographical Revenue

Figure 16 SI-BONE: Key Financials

Figure 17 SI-BONE: Segmental Revenue

Figure 18 SI-BONE: Geographical Revenue

Figure 19 Globus Medical: Key Financials

Figure 20 Globus Medical: Segmental Revenue

Figure 21 Globus Medical: Geographical Revenue

Figure 22 Zyga Technology: Key Financials

Figure 23 Zyga Technology: Segmental Revenue

Figure 24 Zyga Technology: Geographical Revenue

Figure 25 CoorsTek Medical LLC: Key Financials

Figure 26 CoorsTek Medical LLC: Segmental Revenue

Figure 27 CoorsTek Medical LLC: Geographical Revenue

Figure 28 Nutech Medical: Key Financials

Figure 29 Nutech Medical: Segmental Revenue

Figure 30 Nutech Medical: Geographical Revenue

Figure 31 ASPEN MEDICAL PRODUCTS: Key Financials

Figure 32 ASPEN MEDICAL PRODUCTS: Segmental Revenue

Figure 33 ASPEN MEDICAL PRODUCTS: Geographical Revenue

Figure 34 Medtronic: Key Financials

Figure 35 Medtronic: Segmental Revenue

Figure 36 Medtronic: Geographical Revenue

Sacroiliitis Market Scenario


The sacroiliitis market is expected to witness growth during the forecast period. Sacroiliitis is a medical condition where there is inflammation in one or both sacroiliac joints situated in the pelvis and lower back. The function of a sacroiliac joint is to bear the weight of the upper body while standing, walking, and others. The condition can be diagnosed by imaging techniques. Sacroiliitis is caused due to traumatic injury, arthritis, pregnancy, infection, spondylitis, and others. The increasing prevalence of arthritis is the key factor for the market growth. According to the Centers for Disease Control and Prevention (2013to 2015), 22.7% Americans of the total population had arthritis, annually. Thus, such a high prevalence of arthritis and increasing government funding for the healthcare sector enhance the growth of this market.


However, factors such as expensive diagnostic tests and the high cost of surgical procedures are expected to restrict the market growth during the forecast period.


Segmentation


The sacroiliitis market is segmented on the basis of diagnosis, treatment, and end-user. The sacroiliitis industry, by diagnosis, is sub-segmented into imaging tests and anesthetic injections. The imaging tests category includes x-ray, MRI, and CT scan. On the basis of treatment, the market is categorized into medications, joint injections, radiofrequency denervation, electrical stimulation, joint fusion, facet block, chiropractic manipulation, and physical therapy. On the basis of end-user, the market is segmented into hospitals and clinics, pharmacies, and diagnostic centers.


On the basis of region, the sacroiliitis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.


The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players


Some of the key players in the sacroiliitis market are Medacta International, SI-BONE, Globus Medical, Zyga Technology, Nutech Medical, CoorsTek Medical LLC, Aspen Medical Products, Medtronic, and others.


Regional Market Summary


Sacroiliitis Market Share (%), by Region, 2017


Sacroiliitis Market Share.png


Sources: Centers for Disease Control and Prevention


The sacroiliitis market is dominated by North America owing to the high prevalence of arthritis and high healthcare investments within this region. According to the Centers for Disease Control and Prevention by 2040, 78.4 million will have doctor-diagnosed arthritis.


The rising adoption of technologically advanced systems for early diagnosis of diseases also drives the market growth in this region.


It is estimated that Europe stood second in the sacroiliitis market. The increasing prevalence of lower back disorders and the availability of minimally invasive surgical procedures for sacroiliitis drive the market growth in this region. According to The European (2015), sacroiliac joint was the main reason for chronic low back pain in Europe.


Asia-Pacific was projected to be the fastest growing region for the sacroiliitis market. Key factors such as the growing patient pool, the high prevalence of chronic diseases, developing healthcare infrastructure, and increasing research and development activities in the biotechnology sector influence the market in this region. The presence of major market players such as China, India, and Japan drives the market growth.


The Middle East and Africa holds the least share of the sacroiliitis market due to the presence of stringent government policies and poor economies. However, growing awareness among the population, rising government initiatives to improve the healthcare sector, and high investments by private market players in this region can boost the market growth. 


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers


Market Segmentation and Key Market Players


Sacroiliitis Market, by Diagnosis,



  • Imaging tests


    • X-ray

    • MRI

    • CT scan


  • Anesthetic injections


Sacroiliitis Market, by Treatment



  • Medications


    • Pain relievers

    • Muscle relaxants

    • TNF inhibitors


  • Joint injections

  • Radiofrequency denervation

  • Electrical stimulation

  • Joint fusion

  • Facet block

  • Chiropractic manipulation

  • Physical therapy


Sacroiliitis Market, by End-User



  • Hospitals & Clinics

  • Pharmacies

  • Diagnostic Centers


Sacroiliitis Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Sacroiliitis Market, by Key Players



  • Medacta International

  • SI-BONE

  • Globus Medical

  • Zyga Technology

  • Nutech Medical

  • CoorsTek Medical LLC

  • Aspen Medical Products

  • Medtronic

  • Others



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Expensive diagnostic procedures and high costs associated with surgeries can deter sacroiliitis market growth.

The report on sacroiliitis market has imaging tests and anesthetic injections.

Sacroiliitis market report covers joint injections, medications, chiropractic manipulation, electrical stimulation, radiofrequency denervation, facet block, joint fusion, and physical therapy.

Hospitals & clinics, pharmacies, and others are included in sacroiliitis market report.

North America would ensure that its dominance continues in the global sacroiliitis market.